3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Genitourinary
1
Conditions
Urinary Bladder Neoplasms
9
Prostatic Neoplasms
4
Carcinoma, Transitional Cell
4
Urethral Neoplasms
3
Ureteral Neoplasms
2
Testicular Neoplasms
2
Seminoma
2
Ovarian Neoplasms
2
Mesothelioma, Malignant
2
Wilms Tumor
1
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Renal Pelvis and Ureter Urothelial Carcinoma
1
Penile Neoplasms
1
Metastatic Bladder Urothelial Carcinoma
1
Lung Neoplasms
1
Infiltrating Bladder Urothelial Carcinoma
1
Hearing Loss
1
Breast Neoplasms
1
Interventions
Vincristine
16
Cyclophosphamide
16
Filgrastim
13
Etoposide
12
Doxorubicin
12
Radiotherapy
11
Carboplatin
10
X-Rays
9
Dactinomycin
9
Specimen Handling
8
Phantoms, Imaging
8
Magnetic Resonance Spectroscopy
8
Granulocyte Colony-Stimulating Factor
8
Temozolomide
6
Melphalan
6
Ifosfamide
6
Topotecan
5
Polymerase Chain Reaction
5
Peripheral Blood Stem Cell Transplantation
5
Nuclear Medicine Department, Hospital
5
Irinotecan
5
Busulfan
5
Biopsy
5
sargramostim
4
Stem Cell Transplantation
4
Gene Expression Profiling
4
Amplified Fragment Length Polymorphism Analysis
4
Thiotepa
3
Reverse Transcriptase Polymerase Chain Reaction
3
Radiation
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Wilms Tumor
×
Platinum
×
Genitourinary
×
Clear all
NCT05765084
2024-05-16
Immuno-MESODEC
University Hospital, Antwerp
Phase 1/2
Recruiting
15 enrolled